(19)
(11) EP 1 119 773 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.06.2006 Bulletin 2006/25

(45) Mention of the grant of the patent:
20.07.2005 Bulletin 2005/29

(21) Application number: 99951770.9

(22) Date of filing: 05.10.1999
(51) International Patent Classification (IPC): 
G01N 33/68(1980.01)
C07K 14/47(1995.01)
G01N 33/569(1985.01)
C07K 16/18(1995.01)
(86) International application number:
PCT/US1999/023115
(87) International publication number:
WO 2000/022438 (20.04.2000 Gazette 2000/16)

(54)

ASSAY FOR DISEASE RELATED CONFORMATION OF A PROTEIN

TEST ZUM NACHWEIS VON PRIONEN-PROTEINEN DIE IN EINER MIT KRANKHEIT ASSOZIIERTEN KONFORMATIONEN VORLIEGEN

ESSAI DE DETECTION DES PROTEINES PRION DANS UNE CONFORMATION ACCOCIEE A UNE MALADIE


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 09.10.1998 US 169574

(43) Date of publication of application:
01.08.2001 Bulletin 2001/31

(73) Proprietor: The Regents of the University of California
Oakland, CA 94607-5200 (US)

(72) Inventors:
  • PRUSINER, Stanley, B.
    San Francisco, CA 94116 (US)
  • SAFAR, Jiri, G.
    Concord, CA 94518 (US)

(74) Representative: Campbell, Patrick John Henry et al
J.A. Kemp & Co., 14 South Square, Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)


(56) References cited: : 
EP-A- 0 861 900
WO-A-99/42487
WO-A-98/37210
   
  • MEDLINE, Washington DC USA; abstract no. 94184819, abstract line 18 XP002129708 & W. GOLDMAN: " PrP gene and its association with spongiform encephalopathies." BRITISH MEDICAL BULLETIN, vol. 49, no. 4, 1 October 1993 (1993-10-01), pages 839-859, London UK
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).